Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $7.58 | Change: $-0.02 | %Change: -0.26%
Volume: 12,338 | Day High/Low: 7.60/7.38 | 52 Week High/Low: 8.33/1.66
View modes: 
1 star

RE:WF10 2015 Plans direct from the horses mouth....

Glad to see that this management team has learned from past experience and appears that they are covering all required documentation and figures the FDA will ask based on past experience. This...read more
0 stars

RE:RE:P/E ratio of Nasdaq vs TSX

Management have made it clear....at least to me...listen to the last CC...that they are drug developers and do not have the heft to engage in distribution or direct selling. As we have already seen...read more
1.5 stars

RE:WF10 2015 Plans direct from the horses mouth....

This clinical trial, consistent with what Lynn said,has a large sample size (186) . This is needed to examine some of the critical outcomes that will be needed to address in a pre-emptive manner...read more
5 stars

WF10 2015 Plans direct from the horses mouth....

I posed a question on the Nuvo info line re plans to move forward with Phase III testing with WF10 (assuming positive phase II results), and I received the following response: Thanks for your note...read more
5 stars

RE:RE:RE:P/E ratio of Nasdaq vs TSX

I tend to agree with you ronz that a NASDAQ listing ahead of the WF10 results would be the better way to go. This would give the market the opportunity to bid up the stock price before the news...read more
3 stars

RE:RE:P/E ratio of Nasdaq vs TSX

I would think that having the Nasdaq listing ahead of any WF10 trial results would be absolutely paramount as it would allow for an influx of american investors clammering to buy a piece of this stock...read more
3 stars

RE:P/E ratio of Nasdaq vs TSX

From a marketing point of view one would think that a major AND positive announcement (like our WF10 POSITIVE TEST RESULTS !!!! ) just pror to an american listing would surely have a significant and...read more
3.5 stars

P/E ratio of Nasdaq vs TSX

Just curious about the Nasdaq effect on share price, once a listing is secured. Todate, the average p/e for the Nasdaq 100 is 24.7. For the TSX 60 index, the average P/E ratio is 16.7. This is not...read more
1 star

Interesting technology arrangement with Ferndale Pharma

MISSISSAUGA, ON, April 23, 2014 - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration...read more
5 stars

RE:RE:RE:Health Care Stocks the place to be

That is , like the pot calling the kettle black. your ' url/source' refers to a number of sites and companies, such as Stem Cell Investing, Orcha Tech and about 5 other companies, all threads on...read more
1.5 stars

RE:RE:Health Care Stocks the place to be

Well, I do have a following on these boards which is as much a congruence of investment tastes and common subscriber ship to several investment sources . Pour moi, my investments are 70  % internally...read more
4.5 stars

RE:Health Care Stocks the place to be

But one area of the market is a sure bet to keep growing. It's a sector that has made my readers a lot of money... and will continue to make them money for decades to come. You want cheap...read more
2.5 stars

Health Care Stocks the place to be

There's a lot of worry in the market right now.   People are worried about Europe going into recession. They're worried about a Chinese slowdown.   But one area of the market is a sure bet to keep...read more
3.5 stars

RE:RE:RE:WF10 Trials and Implication

If you visit the Nuvo website you are able to click on the contact us tab, fill out the info and submit a question as I did Sunday afternoon. The note I posted was copied and pasted from my email , I...read more
2.5 stars

RE:RE:RE:WF10 Trials and Implication

No one is forcing you to stay invested here. If you are uncomfortable in your investment, sell out. Why waste our time with your repititve and foundless opinions.  rate and reply
3 stars

RE:RE:wf10

geos571 wrote: Our increased investment in WF10 underscores our belief in its potential," stated John London, Nuvo's President and Co-CEO.  "Full ownership of AG will improve our flexibility in...read more
3 stars

RE:wf10

Our increased investment in WF10 underscores our belief in its potential," stated John London, Nuvo's President and Co-CEO.  "Full ownership of AG will improve our flexibility in managing all aspects...read more
5 stars

wf10

The Journal of Immunology, 2013, 190, 68.20 Copyright © 2013 by The American Association of Immunologists, Inc. 68.20 Anti-inflammatory effects of WF10 in a mouse model of rheumatoid arthritis (P5185)...read more
4.5 stars

RE:RE:WF10 Trials and Implication

I have no reason to believe that the information in your post is a fabrication. Forgive me if I point out that this is one of the things wrong with this management group and why there has been an...read more
3 stars

love this sideways action

i'm glad it hasn't continued upward this week.  the need for some sideways action here to consolidate the previous gains and build a base for the next move up is paramaount to that move having any...read more